2000
DOI: 10.1007/s004399900194
|View full text |Cite
|
Sign up to set email alerts
|

Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
1

Year Published

2000
2000
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(13 citation statements)
references
References 0 publications
0
12
1
Order By: Relevance
“…Neuromuscular involvement, with high levels of CK, affected patient 3, though still a child, 4, 5 and 8. The first two, sharing the splice-site alterations on intron 21, showed also the same symptoms excluding hepatomegaly which, however, tends to As previously discussed (Lucchiari et al, 2002), it is difficult to establish any genotypic-phenotypic correlation due to the poor knowledge on the type of domains composing the AGL protein and their sequential disposition (Yang et al, 1992;Okubo et al, 2000). Up to date, the only information available in SWISS-PROT databank concerns the amylo-1,6-glucosidase catalytic domain, supposed to localise in the carboxyterminus of the AGL protein.…”
Section: Resultsmentioning
confidence: 90%
“…Neuromuscular involvement, with high levels of CK, affected patient 3, though still a child, 4, 5 and 8. The first two, sharing the splice-site alterations on intron 21, showed also the same symptoms excluding hepatomegaly which, however, tends to As previously discussed (Lucchiari et al, 2002), it is difficult to establish any genotypic-phenotypic correlation due to the poor knowledge on the type of domains composing the AGL protein and their sequential disposition (Yang et al, 1992;Okubo et al, 2000). Up to date, the only information available in SWISS-PROT databank concerns the amylo-1,6-glucosidase catalytic domain, supposed to localise in the carboxyterminus of the AGL protein.…”
Section: Resultsmentioning
confidence: 90%
“…Debranching enzyme is a monomeric enzyme but has 2 catalytic activities: amylo-1,6-glucosidase and 4-α-glucanotransferase. It is encoded for by the AGL gene, and homozygous or compound heterozygous autosomal recessive mutations result in 2 main subcategories: GSD IIIa and GSD IIIb [30][31][32][33]. Subcategory IIIb is less common (15%) and exclusively hepatic, IIIa being the most common (85%), and presents with hepatopathy, cardiomyopathy, and myopathy with weakness and hyperCKemia [31,33,34].…”
Section: Debranching Enzymementioning
confidence: 99%
“…It is encoded for by the AGL gene, and homozygous or compound heterozygous autosomal recessive mutations result in 2 main subcategories: GSD IIIa and GSD IIIb [30][31][32][33]. Subcategory IIIb is less common (15%) and exclusively hepatic, IIIa being the most common (85%), and presents with hepatopathy, cardiomyopathy, and myopathy with weakness and hyperCKemia [31,33,34]. Some patients can present only with muscle weakness and hyperCKemia and not other overt clinical features [35][36][37][38].…”
Section: Debranching Enzymementioning
confidence: 99%
“…The human gene maps to chromosome 1p21 2 . To study the porcine AGL gene PCR primers (pair 1) were designed using human genomic DNA sequence, exons 26 and 27 3 (EMBL accession numbers , ). The ∼4.2‐kb fragment was cloned and end‐sequenced to verify the identity with AGL .…”
Section: Source and Descriptionmentioning
confidence: 99%